Todos Medical (OTCMKTS:TOMDF) & Modular Medical (NASDAQ:MODD) Head to Head Contrast

Todos Medical (OTCMKTS:TOMDF) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations.

Profitability

This table compares Todos Medical and Modular Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Todos Medical	N/A	N/A	N/A
Modular Medical	N/A	-228.12%	-178.09%

Institutional & Insider Ownership

27.5% of Modular Medical shares are owned by institutional investors. 32.3% of Modular Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Todos Medical and Modular Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Todos Medical	$12.23 million	0.00	-$43.31 million	N/A	N/A
Modular Medical	N/A	N/A	-$17.47 million	($0.68)	-3.25

Modular Medical has lower revenue, but higher earnings than Todos Medical.

Analyst Recommendations

This is a summary of recent ratings and target prices for Todos Medical and Modular Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Todos Medical	0	0	0	0	0.00
Modular Medical	0	0	1	0	3.00

Modular Medical has a consensus price target of $5.00, indicating a potential upside of 126.24%. Given Modular Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Modular Medical is more favorable than Todos Medical.

Risk & Volatility

Todos Medical has a beta of 0.06, indicating that its share price is 94% less volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.

Summary

Modular Medical beats Todos Medical on 7 of the 10 factors compared between the two stocks.

About Todos Medical

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

About Modular Medical

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.